-+ 0.00%
-+ 0.00%
-+ 0.00%

LILLY'S JAYPIRCA (PIRTOBRUTINIB) SIGNIFICANTLY IMPROVED PROGRESSION-FREE SURVIVAL, REDUCING THE RISK OF PROGRESSION OR DEATH BY 80%, VERSUS CHEMOIMMUNOTHERAPY IN PATIENTS WITH TREATMENT-NAÏVE CLL/SLL

Reuters·12/09/2025 12:30:04

Please log in to view news